Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.21 USD | -2.64% | -5.53% | -89.17% |
May. 16 | Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating | MT |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.17% | 67.71M | |
+41.33% | 50.93B | |
-0.42% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.93% | 26.02B | |
-21.93% | 18.9B | |
+7.54% | 13.21B | |
+24.59% | 12.17B | |
+30.35% | 12.16B |
- Stock Market
- Equities
- ANTX Stock
- News AN2 Therapeutics, Inc.
- Oppenheimer Adjusts AN2 Therapeutics Price Target to $24 From $20, Maintains Outperform Rating